Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
Riera, Jordi; Alcántara, Sara; Bonilla, Camilo; Fortuna, Phillip; Blandino-Ortiz, Aaron; Vaz, Ana; Albacete, Carlos; Millán, Pablo; Ricart, Pilar; Boado, María-Victoria; de-Gopegui, Pablo-Ruiz; Teresa, Patricia-Santa; Sandoval, Elena; Pérez-Chomón, Helena; González-Pérez, Alfredo; Duerto, Jorge; Gimeno, Ricardo; Colomina, Joaquín; Gómez, Vanesa; Renedo, Gloria; Naranjo, José; García, Manuel-Alfonso; Rodríguez-Ruiz, Emilio; Silva, Pedro-Eduardo; Pérez, Daniel; Veganzones, Javier; Voces, Roberto; Martínez, Sergi; Blanco-Schweizer, Pablo; García, Marta; Villanueva-Fernández, Héctor; Fuset, María-Paz; Luna, Stephani-María; Martínez-Martínez, María; Argudo, Eduard; Chiscano, Luis; Roncon-Albuquerque-Jr, Roberto
Fecha:
2022
Resumen:
When indicating ECMO in patients with COVID-19, centre case volume, age, driving pressure and the duration of symptoms (not the length of MV) should be taken into account. Large drainage cannula and high PEEP levels during the first days are recommended. https://bit.ly/3DGjGkk
Mostrar el registro completo del ítem
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 4.0 España